Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on the company. HC Wainwright reiterated a buy rating and set a $9.00 target […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. ALIM has been the subject of a number of other reports. Craig Hallum cut their price objective on shares of Alimera Sciences from […]
Note Regarding Forward-Looking Statements Various statements made in this Quarterly Report on Form 10-Q are forward-looking and involve risks and uncertainties. All statements that... | May 4, 2023
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Craig Hallum dropped their target price on Alimera Sciences from $18.00 to $8.00 in a […]
Equities Research Analysts’ new coverage for Sunday, April 30th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlantic American (NASDAQ:AAME). They issued a hold rating on the stock. StockNews.com started coverage on shares of ADDvantage Technologies Group (NASDAQ:AEY). StockNews.com […]